Internal Medicine · Livingston, NJ
NPI
1235120155
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
94 Old Short Hills Road
Livingston, NJ, 07039
Phone (201) 322-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$204K
3,390 services
Medicare patients, 2024
188
Average age 70
Drug cost, 2024
$1.6M
12,091 prescriptions
Company payments, 2025
$300
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nael A Abutabikh was code 99308 (snf e&m), 1,248 times for 51 patients. In total Nael A Abutabikh billed 3,390 services in 30 codes, and Medicare paid $204K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Office | 1,248 | 51 | $63.67 | $79K |
| 99212 Office E&M - Established | Office | 547 | 96 | $45.73 | $25K |
| 99309 SNF E&M | Office | 330 | 35 | $90.71 | $30K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 280 | 63 | $51.47 | $14K |
| 99213 Office E&M - Established | Office | 175 | 80 | $72.38 | $13K |
| 96372 Injection Administration | Office | 163 | 35 | $12.32 | $2,008 |
| 99232 Hospital E&M - Subsequent | Facility | 91 | 19 | $66.53 | $6,054 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 81 | 19 | $0.99 | $80.23 |
| 99214 Office E&M - Established | Office | 69 | 52 | $81.88 | $5,650 |
| 99238 Hospital Discharge Management | Facility | 48 | 31 | $68.92 | $3,308 |
| 99310 SNF E&M | Office | 47 | 17 | $130.68 | $6,142 |
| 99222 Hospital E&M - Initial | Facility | 44 | 29 | $108.88 | $4,791 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 39 | 19 | $0.09 | $3.56 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 34 | 14 | $0.54 | $18.46 |
| 99305 SNF E&M | Office | 30 | 28 | $113.39 | $3,402 |
By year: 2022 $120K for 2,006 services; 2023 $202K for 3,138 services; 2024 $204K for 3,390 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 37 | 28 | $2.99 | $111 |
Medicare prescription drug claims, 2024
In 2024, the drug Nael A Abutabikh prescribed most often to Medicare patients was Atorvastatin Calcium, with 755 prescriptions and refills. In total Nael A Abutabikh wrote 12,091 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 755 | 1,292 | 197 | $8,397 |
| Amlodipine Besylate Generic | 522 | 813 | 131 | $3,386 |
| Metformin Hcl Generic | 264 | 495 | 91 | $1,701 |
| Pantoprazole Sodium Generic | 253 | 280 | 63 | $5,059 |
| Tamsulosin Hcl Generic | 247 | 320 | 57 | $3,852 |
| Gabapentin Generic | 246 | 325 | 61 | $3,030 |
| Omeprazole Generic | 240 | 332 | 93 | $1,708 |
| Naproxen Generic | 239 | 243 | 132 | $6,716 |
| Levothyroxine Sodium Generic | 231 | 410 | 50 | $4,205 |
| Metoprolol Succinate Generic | 202 | 340 | 59 | $3,693 |
| Lisinopril Generic | 201 | 323 | 47 | $1,305 |
| Eliquis Apixaban | 198 | 208 | 28 | $75K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 174 | 225 | 70 | $4,796 |
| Losartan Potassium Generic | 168 | 281 | 44 | $1,330 |
| Diclofenac Sodium Generic | 167 | 238 | 103 | $199K |
Brand drugs: 2,066 claims; generic drugs: 9,875 claims; opioid claims: 55.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nael A Abutabikh $300 ($300 in general payments such as food, travel and fees) from 1 company. The largest payer was Madrigal Pharmaceuticals with $300.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 2 | $300 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.